Aikon Medical Falls Despite First-Half Profit Beat, Stock Down 0.69% on July 22

According to an announcement on July 21, Aikon Medical (01789) disclosed solid first-half 2026 results, with revenue projected to grow about 10% year-over-year and overseas revenue surging about 40% year-over-year, coupled with net profit growth exceeding 20%. However, the stock failed to capitalize on the earnings upside, falling 0.69% on July 22 and trading below key technical support levels on July 23.

The stock declined after a two-month downturn during which it barely maintained its Hong Kong Stock Connect inclusion status. The company's market capitalization of 67.18 billion Hong Kong dollars, as of the review period ending June 30, exceeded the 66.89 billion Hong Kong dollars inclusion threshold by just 0.29 billion Hong Kong dollars, according to Smart Finance.